Corrigendum to "Tankyrase1/2 inhibitor XAV-939 reverts EMT and suggests that PARylation partially regulates aerobic activities in human hepatocytes and HepG2 cells" [Biochem. Pharmacol. 227 (2024) 116445].

De Vos, Kristof; Mavrogiannis, Adamantios; Wolters, Justina Clarinda; Schlenner, Susan; Wierda, Keimpe; Calabuig, Álvaro Cortés; Chinnaraj, Reena; Dermesrobian, Vera; Armoudjian, Yeghig; Jacquemyn, Maarten; Corthout, Nikky; Daelemans, Dirk; Annaert, Pieter

De Vos, Kristof; Mavrogiannis, Adamantios; Wolters, Justina Clarinda; Schlenner, Susan; Wierda, Keimpe; Calabuig, Álvaro Cortés; Chinnaraj, Reena; Dermesrobian, Vera; Armoudjian, Yeghig; Jacquemyn, Maarten; Corthout, Nikky; Daelemans, Dirk; Annaert, Pieter.

Afiliação

De Vos K; Laboratory of Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological sciences, KU Leuven, 3000 Leuven, Belgium.
Mavrogiannis A; Adaptive Immunology, Department of Microbiology, Immunology and Transplantation, KU Leuven, 3000 Leuven, Belgium.
Wolters JC; Section Systems Medicine of Metabolism and Signaling, Department of Pediatrics, University of Groningen, University Medical Center Groningen, Groningen 9713 AV, The Netherlands.
Schlenner S; Adaptive Immunology, Department of Microbiology, Immunology and Transplantation, KU Leuven, 3000 Leuven, Belgium.
Wierda K; VIB-KU Leuven Center for Brain & Disease Research, 3000 Leuven, Belgium; Electrophysiology Unit, VIB-KU Leuven Center for Brain & Disease Research, 3000 Leuven, Belgium.
Calabuig ÁC; KU Leuven Genomics Core, Department of Human Genetics, KU Leuven, 3000 Leuven, Belgium.
Chinnaraj R; KU Leuven Flow and Mass Cytometry Facility, Department of Microbiology, Immunology and Transplantation, KU Leuven, 3000 Leuven, Belgium.
Dermesrobian V; KU Leuven Flow and Mass Cytometry Facility, Department of Microbiology, Immunology and Transplantation, KU Leuven, 3000 Leuven, Belgium.
Armoudjian Y; BioNotus GCV, 2845 Niel, Belgium.
Jacquemyn M; Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, KU Leuven, Rega Institute, 3000 Leuven, Belgium.
Corthout N; VIB-KU Leuven Center for Brain & Disease Research, 3000 Leuven, Belgium; VIB Bio Imaging Core, 3000 Leuven, Belgium.
Daelemans D; Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, KU Leuven, Rega Institute, 3000 Leuven, Belgium.
Annaert P; Laboratory of Drug Delivery and Disposition, Department of Pharmaceutical and Pharmacological sciences, KU Leuven, 3000 Leuven, Belgium; BioNotus GCV, 2845 Niel, Belgium. Electronic address: pieter.annaert@kuleuven.be.

Biochem Pharmacol ; 229: 116497, 2024 Aug 22.

Article em En | MEDLINE | ID: mdl-39178689

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Biochem Pharmacol / Biochem. pharmacol / Biochemical pharmacology Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Bélgica

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google